Chinese General Practice ›› 2022, Vol. 25 ›› Issue (24): 2975-2983.DOI: 10.12114/j.issn.1007-9572.2022.0120
Special Issue: 高血压最新文章合集
• Article • Previous Articles Next Articles
Received:
2022-02-25
Revised:
2022-03-09
Published:
2022-08-20
Online:
2022-06-30
Contact:
Ningling SUN
About author:
通讯作者:
孙宁玲
作者简介:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0120
项目 | 性别 | SBP(mm Hg) | DBP(mm Hg) | HR(次/min) |
---|---|---|---|---|
以月为时间粒度 | 男 | 140±19a | 89±12a | 73±12a |
女 | 137±18 | 83±11 | 71±11 | |
以日为时间粒度 | 男 | 140±19a | 89±12a | 73±12a |
女 | 137±18 | 83±11 | 71±11 | |
以每日不同时段为时间粒度 | 男 | 140±19a | 89±12a | 73±12a |
女 | 137±14 | 83±11 | 71±11 |
Table 1 Comparison of mean systolic blood pressure,diastolic blood pressure and heart rate at different time granularities between male and female hypertensive patients quarantined at home
项目 | 性别 | SBP(mm Hg) | DBP(mm Hg) | HR(次/min) |
---|---|---|---|---|
以月为时间粒度 | 男 | 140±19a | 89±12a | 73±12a |
女 | 137±18 | 83±11 | 71±11 | |
以日为时间粒度 | 男 | 140±19a | 89±12a | 73±12a |
女 | 137±18 | 83±11 | 71±11 | |
以每日不同时段为时间粒度 | 男 | 140±19a | 89±12a | 73±12a |
女 | 137±14 | 83±11 | 71±11 |
Figure 1 Comparison of mean systolic blood pressure,diastolic blood pressure and heart rate between male and female hypertensive patients quarantined at home by month
Figure 2 Comparison of mean daily systolic blood pressure,diastolic blood pressure and heart rate in male and female hypertensive patients quarantined at home during the 118-day period
Figure 3 Comparison of mean systolic blood pressure,diastolic blood pressure and heart rate at different time granularities per day between male and female hypertensive patients quarantined at home
Figure 4 Mean systolic blood pressure,diastolic blood pressure and heart rate in male and female hypertensive patients quarantined at home before and after the traffic control implemented on January 23,2020
性别 | 日期 | SBP(mm Hg) | DBP(mm Hg) | HR(次/min) |
---|---|---|---|---|
男 | 1月23日前 | 142±19 | 90±12 | 72±12 |
1月23日后 | 138±18 | 88±11 | 73±12 | |
女 | 1月23日前 | 139±18 | 83±11 | 70±10 |
1月23日后 | 136±18 | 82±11 | 71±11 |
Table 2 Changes of mean systolic blood pressure,diastolic blood pressure and heart rate in male and female hypertensive patients quarantined at home before and after the traffic control
性别 | 日期 | SBP(mm Hg) | DBP(mm Hg) | HR(次/min) |
---|---|---|---|---|
男 | 1月23日前 | 142±19 | 90±12 | 72±12 |
1月23日后 | 138±18 | 88±11 | 73±12 | |
女 | 1月23日前 | 139±18 | 83±11 | 70±10 |
1月23日后 | 136±18 | 82±11 | 71±11 |
Figure 8 Distribution of blood pressure measurement frequency at different time granularities per day in male and female hypertensive patients quarantined at home
Figure 9 Comparison of blood pressure measurement frequency at different time granularities per day in male and female hypertensive patients quarantined at home before and after the traffic control
时间 | 例数 | 男 | 女 |
---|---|---|---|
2020-01-23前 | 10 631 | 7 604(71.5) | 3 027(28.5) |
2020-01-23后 | 13 814 | 10 379(75.1) | 3 435(24.9) |
合计 | 24 445 | 17 983(73.6) | 6 462(26.4) |
Table 3 Blood pressure measurement times in male and female hypertensive patients quarantined at home before and after the traffic control
时间 | 例数 | 男 | 女 |
---|---|---|---|
2020-01-23前 | 10 631 | 7 604(71.5) | 3 027(28.5) |
2020-01-23后 | 13 814 | 10 379(75.1) | 3 435(24.9) |
合计 | 24 445 | 17 983(73.6) | 6 462(26.4) |
自变量 | 因变量 | 回归系数 | 标准误 | Z值 | 95%CI | P值 |
---|---|---|---|---|---|---|
年龄 | SBP | 2.02×10-1 | 1.09×10-1 | 1.84 | (-1.30×10-2,4.16×10-1) | 0.066 |
DBP | -3.32×10-3 | 5.24×10-2 | -0.06 | (-1.06×10-1,9.95×10-2) | 0.949 | |
HR | -5.79×10-2 | 6.23×10-2 | -0.93 | (-1.80×10-1,6.42×10-2) | 0.353 | |
累计死亡数 | SBP | -1.08×10-3 | 4.92×10-4 | -2.20 | (-1.16×10-4,-2.04×10-3) | 0.028 |
DBP | -6.35×10-4 | 2.68×10-4 | -2.37 | (-1.10×10-4,-1.16×10-3) | 0.018 | |
HR | -3.25×10-4 | 2.65×10-4 | -1.23 | (-8.44×10-4,1.93×10-4) | 0.219 | |
每日新发病例数 | SBP | -2.23×10-4 | 5.31×10-4 | -0.42 | (-1.26×10-3,8.17×10-4) | 0.674 |
DBP | -3.52×10-5 | 3.34×10-4 | -0.11 | (-6.91×10-4,6.20×10-4) | 0.916 | |
HR | 2.53×10-4 | 2.12×10-4 | 1.20 | (-1.62×10-4,6.68×10-4) | 0.232 | |
以月为时间粒度 | SBP | -1.46×10-1 | 9.12×10-2 | -1.61 | (-3.25×10-1,3.22×10-2) | 0.108 |
DBP | -1.12×10-1 | 4.68×10-2 | -2.38 | (-1.98×10-2,-2.03×10-1) | 0.017 | |
HR | 4.75×10-2 | 6.39×10-2 | 0.74 | (-7.79×10-2,1.73×10-1) | 0.458 | |
以周为时间粒度 | SBP | 2.15×10-2 | 3.36×10-2 | 0.64 | (-4.44×10-2,8.74×10-2) | 0.523 |
DBP | 1.67×10-2 | 1.93×10-2 | 0.86 | (-2.12×10-2,5.46×10-2) | 0.388 | |
HR | 1.43×10-2 | 2.23×10-2 | 0.64 | (-2.94×10-2,5.80×10-2) | 0.522 | |
以每日不同时段为时间粒度 | SBP | 4.64×10-2 | 1.10×10-1 | 0.42 | (-1.70×10-1,2.62×10-1) | 0.674 |
DBP | 6.85×10-2 | 6.51×10-2 | 1.05 | (-5.91×10-2,1.96×10-1) | 0.293 | |
HR | -2.55×10-2 | 5.50×10-2 | -0.46 | (-1.33×10-1,8.22×10-2) | 0.642 | |
交通管制 | SBP | -1.65 | 1.27 | -1.30 | (-4.14,8.37×10-1) | 0.193 |
DBP | -6.38×10-1 | 7.60×10-1 | -0.84 | (-2.13,8.52×10-1) | 0.401 | |
HR | 2.02 | 6.85×10-1 | 2.94 | (6.72×10-1,3.36) | 0.003 | |
常数 | SBP | 1.30×102 | 5.98 | 21.68 | (1.18×102,1.41×102) | <0.001 |
DBP | 8.79×10 | 2.98 | 29.52 | (8.21×10,9.38×10) | <0.001 | |
HR | 7.37×10 | 3.48 | 21.20 | (6.69×10,8.05×10) | <0.001 | |
ARMA模型 | ||||||
ar L1 | SBP | 3.39×10-1 | 9.00×10-2 | 3.76 | (1.62×10-1,5.15×10-1) | <0.001 |
DBP | 2.16×10-1 | 9.51×10-2 | 2.27 | (2.95×10-2,4.02×10-1 | 0.023 | |
HR | 4.07×10-1 | 9.39×10-2 | 4.33 | (2.23×10-1,5.91×10-1) | <0.001 | |
ARIMAX模型 | SBP | 最大似然估计=-257.195 2,χ2=56.77,P=0.000 1 | ||||
DBP | 最大似然估计=-187.936 9,χ2=42.67,P=0.000 1 | |||||
HR | 最大似然估计=-192.956 1,χ2=31.27,P=0.000 1 |
Table 4 ARIMAX multivariate regression analysis of the association of systolic blood pressure,diastolic blood pressure land heart rate with age,cumulative confirmed COVID-9 deaths,number of confirmed COVID-19 cases per day,and temporal granularities as well as the traffic control
自变量 | 因变量 | 回归系数 | 标准误 | Z值 | 95%CI | P值 |
---|---|---|---|---|---|---|
年龄 | SBP | 2.02×10-1 | 1.09×10-1 | 1.84 | (-1.30×10-2,4.16×10-1) | 0.066 |
DBP | -3.32×10-3 | 5.24×10-2 | -0.06 | (-1.06×10-1,9.95×10-2) | 0.949 | |
HR | -5.79×10-2 | 6.23×10-2 | -0.93 | (-1.80×10-1,6.42×10-2) | 0.353 | |
累计死亡数 | SBP | -1.08×10-3 | 4.92×10-4 | -2.20 | (-1.16×10-4,-2.04×10-3) | 0.028 |
DBP | -6.35×10-4 | 2.68×10-4 | -2.37 | (-1.10×10-4,-1.16×10-3) | 0.018 | |
HR | -3.25×10-4 | 2.65×10-4 | -1.23 | (-8.44×10-4,1.93×10-4) | 0.219 | |
每日新发病例数 | SBP | -2.23×10-4 | 5.31×10-4 | -0.42 | (-1.26×10-3,8.17×10-4) | 0.674 |
DBP | -3.52×10-5 | 3.34×10-4 | -0.11 | (-6.91×10-4,6.20×10-4) | 0.916 | |
HR | 2.53×10-4 | 2.12×10-4 | 1.20 | (-1.62×10-4,6.68×10-4) | 0.232 | |
以月为时间粒度 | SBP | -1.46×10-1 | 9.12×10-2 | -1.61 | (-3.25×10-1,3.22×10-2) | 0.108 |
DBP | -1.12×10-1 | 4.68×10-2 | -2.38 | (-1.98×10-2,-2.03×10-1) | 0.017 | |
HR | 4.75×10-2 | 6.39×10-2 | 0.74 | (-7.79×10-2,1.73×10-1) | 0.458 | |
以周为时间粒度 | SBP | 2.15×10-2 | 3.36×10-2 | 0.64 | (-4.44×10-2,8.74×10-2) | 0.523 |
DBP | 1.67×10-2 | 1.93×10-2 | 0.86 | (-2.12×10-2,5.46×10-2) | 0.388 | |
HR | 1.43×10-2 | 2.23×10-2 | 0.64 | (-2.94×10-2,5.80×10-2) | 0.522 | |
以每日不同时段为时间粒度 | SBP | 4.64×10-2 | 1.10×10-1 | 0.42 | (-1.70×10-1,2.62×10-1) | 0.674 |
DBP | 6.85×10-2 | 6.51×10-2 | 1.05 | (-5.91×10-2,1.96×10-1) | 0.293 | |
HR | -2.55×10-2 | 5.50×10-2 | -0.46 | (-1.33×10-1,8.22×10-2) | 0.642 | |
交通管制 | SBP | -1.65 | 1.27 | -1.30 | (-4.14,8.37×10-1) | 0.193 |
DBP | -6.38×10-1 | 7.60×10-1 | -0.84 | (-2.13,8.52×10-1) | 0.401 | |
HR | 2.02 | 6.85×10-1 | 2.94 | (6.72×10-1,3.36) | 0.003 | |
常数 | SBP | 1.30×102 | 5.98 | 21.68 | (1.18×102,1.41×102) | <0.001 |
DBP | 8.79×10 | 2.98 | 29.52 | (8.21×10,9.38×10) | <0.001 | |
HR | 7.37×10 | 3.48 | 21.20 | (6.69×10,8.05×10) | <0.001 | |
ARMA模型 | ||||||
ar L1 | SBP | 3.39×10-1 | 9.00×10-2 | 3.76 | (1.62×10-1,5.15×10-1) | <0.001 |
DBP | 2.16×10-1 | 9.51×10-2 | 2.27 | (2.95×10-2,4.02×10-1 | 0.023 | |
HR | 4.07×10-1 | 9.39×10-2 | 4.33 | (2.23×10-1,5.91×10-1) | <0.001 | |
ARIMAX模型 | SBP | 最大似然估计=-257.195 2,χ2=56.77,P=0.000 1 | ||||
DBP | 最大似然估计=-187.936 9,χ2=42.67,P=0.000 1 | |||||
HR | 最大似然估计=-192.956 1,χ2=31.27,P=0.000 1 |
变量 | 回归系数 | 标准误 | Z值 | 95%置信区间 | P值 | |
---|---|---|---|---|---|---|
血压测量次数 | ||||||
年龄 | -5.07 | 1.66 | -3.05 | (-8.32,-1.81) | 0.002 | |
累计死亡数 | 3.54×10-2 | 1.14×10-2 | 3.11 | (1.31×10-2,5.77×10-2) | 0.002 | |
每日新发病例数 | 3.71×10-3 | 8.02×10-3 | 0.46 | (-1.20×10-2,1.94×10-2) | 0.643 | |
以月为时间粒度 | 6.81 | 1.78 | 3.82 | (3.32,1.03×10) | <0.001 | |
以周为时间粒度 | -7.24×10-1 | 7.79×10-1 | -0.93 | (-2.25,8.02×10-1) | 0.353 | |
以每日不同时段为时间粒度 | -1.82 | 2.07 | -0.88 | (-5.88,2.24) | 0.379 | |
交通管制 | -1.74×10 | 2.50×10 | -0.70 | (-6.65×10,3.16×10) | 0.486 | |
常数 | 5.45×102 | 8.60×10 | 6.33 | (3.76×102,7.13×102) | <0.001 | |
ARMA模型 | ||||||
ar L1 | 4.31×10-1 | 1.08×10-1 | 4 | (2.19×10-1,6.42×10-1) | <0.001 |
Table 5 ARIMAX multivariate regression analysis of the association of blood pressure measurement frequency with age,cumulative confirmed COVID-9 deaths,number of confirmed COVID-19 cases per day,and temporal granularitiesas well as the traffic control
变量 | 回归系数 | 标准误 | Z值 | 95%置信区间 | P值 | |
---|---|---|---|---|---|---|
血压测量次数 | ||||||
年龄 | -5.07 | 1.66 | -3.05 | (-8.32,-1.81) | 0.002 | |
累计死亡数 | 3.54×10-2 | 1.14×10-2 | 3.11 | (1.31×10-2,5.77×10-2) | 0.002 | |
每日新发病例数 | 3.71×10-3 | 8.02×10-3 | 0.46 | (-1.20×10-2,1.94×10-2) | 0.643 | |
以月为时间粒度 | 6.81 | 1.78 | 3.82 | (3.32,1.03×10) | <0.001 | |
以周为时间粒度 | -7.24×10-1 | 7.79×10-1 | -0.93 | (-2.25,8.02×10-1) | 0.353 | |
以每日不同时段为时间粒度 | -1.82 | 2.07 | -0.88 | (-5.88,2.24) | 0.379 | |
交通管制 | -1.74×10 | 2.50×10 | -0.70 | (-6.65×10,3.16×10) | 0.486 | |
常数 | 5.45×102 | 8.60×10 | 6.33 | (3.76×102,7.13×102) | <0.001 | |
ARMA模型 | ||||||
ar L1 | 4.31×10-1 | 1.08×10-1 | 4 | (2.19×10-1,6.42×10-1) | <0.001 |
[1] |
|
[2] |
国家卫生健康委员会.截至5月11日24时新型冠状病毒肺炎疫情最新情况[EB/OL].(2020-05-12)[2022-01-20].
|
[3] | |
[4] |
|
[5] |
吕建军,彭凯,张研. 可穿戴技术在健康领域发展的SWOT分析[J]. 中国社会医学杂志,2016,33(5):477-479. DOI:10.3969/j.issn.1673-5625.2016.05.023.
|
[6] |
孟文文,章洁,麻玉秀,等. 基于云平台的远程监测及综合管理对高血压患者血压变异性的影响[J]. 中华高血压杂志,2018,26(7):639-643. DOI:10.16439/j.cnki.1673-7245.2018.07.016.
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组. 新型冠状病毒肺炎流行病学特征分析[J]. 中华流行病学杂志,2020,41(2):145-151. DOI:10.3760/cma.j.issn.0254-6450.2020.02.003.
|
[15] |
|
[16] |
|
[17] |
|
[18] |
县域医院院长联盟慢病管理专业委员会高血压学组. 新型冠状病毒感染疫情下县域高血压管理的专家建议[J]. 中国全科医学,2020,23(7):770-773. DOI:10.12114/j.issn.1007-9572.2020.00.303.
|
[1] | ZHANG Shuai, LI Qin, LI Dongfeng, XIAO Jinping, LI Yunpeng. A Prospective Cohort Study of Solid Fuels Use and Risk of Hypertension in Chinese Older Adults [J]. Chinese General Practice, 2023, 26(32): 4001-4006. |
[2] | XIAO Liqi, YANG Li, CUI Saixian, ZHANG Yayuan, WANG Yulu, HE Yan. Advances in the Association of High Salt-induced Gut Microbiota Disturbances with Salt-sensitive Blood Pressure [J]. Chinese General Practice, 2023, 26(29): 3704-3709. |
[3] | ZHANG Yunsheng, ZHANG Peng, JIN Yujing, GAO Ying. Association of Blood Pressure Level with the Risk of Chronic Kidney Disease among the Elderly in Longevity Areas of China [J]. Chinese General Practice, 2023, 26(28): 3502-3506. |
[4] | CHENG Xiaoran, ZHANG Xiaotian, LI Mingyue, CHENG Haozhe, TANG Haoqing, ZHENG Huixian, ZHANG Baisong, LIU Xiaoyun. Impact of Chronic Diseases Follow-up on Health Behaviors and Blood Pressure/Glucose Control of Patients with Hypertension and Diabetes in the Context of Treatment-prevention Integration [J]. Chinese General Practice, 2023, 26(28): 3482-3488. |
[5] | BIAN Lili, LI Xiaoxiao, DU Xueping, DAI Qinfang, WU Lin, SONG Beibei. Risk Stratification of Atherosclerotic Cardiovascular Disease and Lipid Goal Attainment in Hypertensive Patients Registered in Community [J]. Chinese General Practice, 2023, 26(27): 3388-3391. |
[6] | ZHAO Wei, TANG Rongjie, YANG Shanshan, YANG Fang, SUN Feng, LIAN Qiufang. The Role and Molecules Mechanism of Klotho in Renal Injury in Salt-sensitive Hypertension [J]. Chinese General Practice, 2023, 26(24): 3042-3049. |
[7] | ZHANG Yong, CAI Xiang, NING Feifei, LIANG Xiao, GUO Ning. Comparative Study of the Efficacy and Safety of Sacubitril/Valsartan and Dapagliflozin in the Treatment of Dilated Cardiomyopathy with Low Blood Pressure [J]. Chinese General Practice, 2023, 26(23): 2912-2917. |
[8] | ZUO Xu, HUANG Zhaolan, LU Biao. Differences between the First and Another 3-day Blood Pressure Levels and Associated Factors in a Self-reported Non-hypertensive Population Aged 35-64 Years [J]. Chinese General Practice, 2023, 26(22): 2771-2777. |
[9] | WU Jian, YU Chengcheng, YANG Yinmei, XIA Qingyun, LI Quanman, FU Xiaoli. COVID-19 Vaccination Behavior and Its Influencing Factors among the Elderly in Four Regions of China [J]. Chinese General Practice, 2023, 26(22): 2763-2770. |
[10] | FENG Jia, WANG Jie, YU Dan, LIU Yongheng, ZHAO Weidong, TIAN Hongyuan. Analysis of Research Hotspots of Multiple Chronic Conditions in the Elderly in 2010-2021 [J]. Chinese General Practice, 2023, 26(21): 2574-2580. |
[11] | FEI Min, LEI Si, XU Yan, YE Yun, ZHUO Hui, ZHANG Hui, LUO Yingquan. Association of Obstructive Sleep Apnea-hypopnea Syndrome with Blood Pressure Variability and Heart Rate Variability in Patients with Hypertension [J]. Chinese General Practice, 2023, 26(20): 2459-2468. |
[12] | HE Mei, LI Hui, MU Lifeng, YANG Ming. Effect of Azovudine on Hepatic and Renal Function in Patients with COVID-19: a Case Series Study [J]. Chinese General Practice, 2023, 26(20): 2476-2481. |
[13] | YU Tong, YANG Yi, DU Shihong, DING Zihao, HONG Xiuqin. Correlation of Shearing Force and Estradiol with Hypertension [J]. Chinese General Practice, 2023, 26(20): 2469-2475,2495. |
[14] | TIAN Meixiang, ZHANG Zhengyi. Standard Management of Hypertension During the Preparation for Pregnancy [J]. Chinese General Practice, 2023, 26(18): 2190-2194. |
[15] | LIU Hai, HUANG Guanhua. The Significance of High Normal Blood Pressure for Children and Adolescents [J]. Chinese General Practice, 2023, 26(18): 2183-2189. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||